{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:51Z","timestamp":1787020851010,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T00:00:00Z","timestamp":1563753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13104-019-4454-2","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T09:03:26Z","timestamp":1563786206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3355-4507","authenticated-orcid":false,"given":"Edmund T.","family":"Nartey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond A.","family":"Tetteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Yankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aukje K.","family":"Mantel-Teeuwisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert G. M.","family":"Leufkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N. O.","family":"Dodoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Lartey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,22]]},"reference":[{"key":"4454_CR1","first-page":"2013","volume-title":"Global update on HIV treatment 2013: results, impact and opportunities","author":"World Health Organisation (WHO)","year":"2013","unstructured":"World Health Organisation (WHO). Global update on HIV treatment 2013: results, impact and opportunities. Geneva: WHO; 2013. p. 2013."},{"key":"4454_CR2","unstructured":"Ghana AIDS Commisssion (GAC). Ghana\u2019s progress report on the United Nations General Assembly Special Session (UNGASS) declaration of commitment on HIV and AIDS Geneva, Switzerland: GAC; 2013."},{"key":"4454_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1472-6904-12-7","volume":"12","author":"GI Eluwa","year":"2012","unstructured":"Eluwa GI, Badru T, Agu KA, Akpoigbe KJ, Chabikuli O, Hamelmann C. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria. BMC Clin Pharmacol. 2012;12:7.","journal-title":"BMC Clin Pharmacol"},{"issue":"10","key":"4454_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1093\/cid\/ciu123","volume":"58","author":"M Estrella","year":"2014","unstructured":"Estrella M, Moosa M, Nachega J. Risk and benefits of tenofovir in the context of kidney dysfunction in sub-Sarahan Africa. CID. 2014;58(10):1481\u20133.","journal-title":"CID"},{"key":"4454_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1001\/jama.292.2.191","volume":"292","author":"JE Gallant","year":"2004","unstructured":"Gallant JE, Staszewski S, Pozniak AL, DeJesus E, Suleiman JM, Miller MD, et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA. 2004;292:191\u2013201.","journal-title":"JAMA"},{"key":"4454_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/QAI.0b013e3181be6be2","volume":"53","author":"M Horberg","year":"2010","unstructured":"Horberg M, Tang B, Towner W, Silverberg M, Bersoff-Matcha S, Hurley L, et al. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010;53:62\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4454_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3109\/00365548.2011.572906","volume":"43","author":"L Calza","year":"2011","unstructured":"Calza L, Trapani F, Tedeschi S, Piergentili B, Manfredi R, Colangeli V, et al. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naive patients. Scand J Infect Dis. 2011;43:656\u201360.","journal-title":"Scand J Infect Dis"},{"key":"4454_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-6405-9-19","volume":"9","author":"AC Chua","year":"2012","unstructured":"Chua AC, Llorin RM, Lai K, Cavailler P, Law HL. Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort. AIDS Res Ther. 2012;9:19.","journal-title":"AIDS Res Ther"},{"key":"4454_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1089\/aid.2009.0261","volume":"26","author":"P De Beaudrap","year":"2010","unstructured":"De Beaudrap P, Diallo MB, Landman R, Gueye NF, Ndiaye I, Diouf A, et al. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215). AIDS Res Hum Retroviruses. 2010;26:1221\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"4454_CR10","doi-asserted-by":"publisher","first-page":"e22661","DOI":"10.1371\/journal.pone.0022661","volume":"6","author":"T Nishijima","year":"2011","unstructured":"Nishijima T, Komatsu H, Gatanaga H, Aoki T, Watanabe K, Kinai E, et al. Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients. PLoS ONE. 2011;6:e22661.","journal-title":"PLoS ONE"},{"key":"4454_CR11","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1086\/655681","volume":"51","author":"RD Cooper","year":"2010","unstructured":"Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Clin Infect Dis. 2010;51:496\u2013505.","journal-title":"Clin Infect Dis"},{"key":"4454_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.biopha.2007.04.008","volume":"62","author":"G Madeddu","year":"2008","unstructured":"Madeddu G, Bonfanti P, De Socio GV, Carradori S, Grosso C, Marconi P, et al. Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project. Biomed Pharmacother. 2008;62:6\u201311.","journal-title":"Biomed Pharmacother"},{"key":"4454_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1086\/524061","volume":"197","author":"M Goicoechea","year":"2008","unstructured":"Goicoechea M, Liu S, Best B, Sun S, Jain S, Kemper C, et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis. 2008;197:102\u20138.","journal-title":"J Infect Dis"},{"key":"4454_CR14","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s11096-015-0132-1","volume":"37","author":"PR Quesada","year":"2015","unstructured":"Quesada PR, Esteban LL, Garcia JR, Sanchez RV, Garcia TM, Alonso-Vega GG, et al. Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients. Int J Clin Pharm. 2015;37:865\u201372.","journal-title":"Int J Clin Pharm"},{"key":"4454_CR15","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/tmi.12446","volume":"20","author":"M Kamkuemah","year":"2015","unstructured":"Kamkuemah M, Kaplan R, Bekker LG, Little F, Myer L. Renal impairment in HIV-infected patients initiating tenofovir-containing antiretroviral therapy regimens in a Primary Healthcare Setting in South Africa. Trop Med Int Health. 2015;20:518\u201326.","journal-title":"Trop Med Int Health"},{"key":"4454_CR16","volume-title":"Consolidated guideliness for treatment of persons living with HIV","author":"World Health Organisation (WHO)","year":"2015","unstructured":"World Health Organisation (WHO). Consolidated guideliness for treatment of persons living with HIV. Geneva: WHO; 2015."},{"key":"4454_CR17","unstructured":"National AIDS Control Program (NACP). Guidelines for antiretroviral therapy in Ghana. Accra; 2014."},{"key":"4454_CR18","doi-asserted-by":"publisher","first-page":"e17609","DOI":"10.1371\/journal.pone.0017609","volume":"6","author":"H Bygrave","year":"2011","unstructured":"Bygrave H, Kranzer K, Hilderbrand K, Jouquet G, Goemaere E, Vlahakis N, et al. Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho. PLoS ONE. 2011;6:e17609.","journal-title":"PLoS ONE"},{"key":"4454_CR19","unstructured":"Korle-Bu Teaching Hospital (KBTH). Korle-Bu teaching hospital annual report-2012. Accra. Ghana: KBTH 2012."},{"key":"4454_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1197\/aemj.9.1.27","volume":"9","author":"DL Karras","year":"2002","unstructured":"Karras DL, Helpern KL, Riley LJ, Hughes L, Gaughan JP. Urine dipstick as screening test for serum creatinine elevation in emergency department patients with severe hypertension. Acad Emerg Med. 2002;9:27\u201334.","journal-title":"Acad Emerg Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13104-019-4454-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-019-4454-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T19:23:05Z","timestamp":1595272985000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-019-4454-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,22]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4454"],"URL":"https:\/\/doi.org\/10.1186\/s13104-019-4454-2","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,22]]},"assertion":[{"value":"1 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent from each study participant was not obtained as the study was retrospective and involved using intuitional database. However approval for this waiver in addition to approval for the entire study protocol was obtained from the College of Health Sciences Ethical and Protocol Review Committee of the University of Ghana [Protocol Identification Approval ID: MS-Et\/M.6-P.5.3\/2009-10].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}